investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

HBV Drug Development

John Tavis

1 Collaborator(s)

Funding source

Industry
This is an early-stage drug discovery project to identify novel inhibitors of HBV as a liver cancer preventative.

Related projects

Xin Wei Wang

The role of cancer stem cells in Liver cancer heterogeneity and subtypes

Liver and intrahepatic bile ducts

Pathology

Xin Chen

Molecular Genetics of Liver Cancers

Liver and intrahepatic bile ducts

Pathology

Xin Wei Wang

The Role of Cancer Stem Cells in Liver Cancer Heterogeneity and Subtypes

Liver and intrahepatic bile ducts

Pathology

Frank Gonzalez

Xenobiotic Receptors – Rockville

Liver and intrahepatic bile ducts

Pathology

Xin Wei Wang

Molecular signatures for liver cancer diagnosis and treatment stratification

Liver and intrahepatic bile ducts

Pathology

Hiroaki Mitsuya

Development of Novel Agents Active against Hepatitis B Virus

Liver and intrahepatic bile ducts

Pathology

Paul J Brindley

Role of Liver Fluke Granulin in Cholangiocarcinogenesis

Liver and intrahepatic bile ducts

Pathology

Xin Wei Wang

Molecular Signatures for Liver Cancer Diagnosis and Treatment Stratification

Liver and intrahepatic bile ducts

Pathology

John Tavis

N-hydroxyisoquinolinediones as HCC Preventatives

Liver and intrahepatic bile ducts

Pathology